Waban, MA, United States of America

Chung-Wei Lee

This inventor holds 5 USPTO granted patents and 6 published patent applications. Top assignee: Axcella Health Inc.. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chung-Wei Lee. Retrieved from https://idiyas.com/inventor/chung-wei-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Newton, MA (US) (2018)
  • Waban, MA (US) (2019 - 2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Chung-Wei Lee

Introduction

Chung-Wei Lee is a notable inventor based in Waban, MA, who has made significant contributions to the field of pharmaceutical compositions. With a total of five patents to his name, he has focused on developing innovative solutions for liver diseases.

Latest Patents

One of his latest patents involves amino acid compositions and methods for the treatment of liver diseases. This disclosure provides pharmaceutical compositions comprising amino acid entities and outlines their uses. The methods described aim to improve liver function and treat liver diseases by administering an effective amount of these compositions to subjects in need.

Career Highlights

Chung-Wei Lee is currently associated with Axcella Health Inc., where he continues to work on groundbreaking research and development in the pharmaceutical sector. His expertise in amino acid compositions has positioned him as a key player in the fight against liver diseases.

Collaborations

Some of his notable coworkers include Michael Hamill and Raffi Afeyan, who contribute to the innovative environment at Axcella Health Inc.

Conclusion

Chung-Wei Lee's work in developing amino acid compositions for liver disease treatment showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…